Expression of drug-resistance-related proteins in nasopharyngeal cancer (NPC) patients treated with cisplatin-based concurrent chemoradiotherapy

Authors :: M-J. Ahn
Sunmi Kang
J.W. Kim
Ji-Youn Han
Chung Yong Kim
Hyunna Lee
Young Sil Hwang
Jung-Joo Choi
Ji Yun Jeong
Source :: Journal of Clinical Oncology. 28:5551-5551
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: 5551 Background: We evaluated the prognostic significance of excision repair cross-complementation group 1 protein (ERCC1), thymidylate synthase (TS), and Bax in patients with nasopharyngeal cancer...

Subjects :: Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
biology
business.industry
Drug resistance
Thymidylate synthase
Concurrent chemoradiotherapy
Internal medicine
medicine
biology.protein
In patient
ERCC1
business
Nucleotide excision repair
Nasopharyngeal cancer
medicine.drug

Full Text Access

Tools